Pharmafile Logo

Research Partnership has published a new Living with Lupus (SLE) market report for 2017

February 22, 2017 | Living with, Patient journey, lupus 

SLE is a progressive and debilitating disease which affects 5 million people worldwide.

Our new syndicated report, based on research with over 250 patients in US, France and Germany, helps pharmaceutical companies with products in this disease area gain a deeper understanding of patients’ attitudes to SLE and the impact it has on their lives, attitudes to SLE treatment, as well as unmet needs in all-round care. 

http://www.researchpartnership.com/news/2017/02/new-living-with-living-with-lupus-(sle)-market-repor…

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Quantitative specialist joins Research Partnership, London

Global healthcare market research consultancy Research Partnership has appointed Roy Rogers as a Quantitative Director in their UK offices in London

Webcast

Amplifying the patient voice: How to conduct patient research sensitively to uncover emotional insights

Webcast

The power of a good story: Turn your insights into effective storytelling with data visualisation

Article

How will COVID-19 affect uptake of vaccinations against other diseases?

Podcast

Living With Chronic Illness (Series one)

Webcast

China: How pharma can maximize success in this rapidly changing emerging market

Article

Inhale, Exhale: The struggle of living with Severe Asthma and Severe Eosinophilic Asthma

Infographic

Migraine market snapshot

Webcast

Monitoring the impact of COVID-19 on the market access landscape

Live webinar from Singapore

Digital #marcomms: How to evaluate and optimise marketing activities impacted by COVID-19